DNA methylation is not only crucial for normal physiology but it is also involved in a myriad of diseases, which has raised wide interest in the development of methods for 
generating quantitative DNA methylation profiles in clinical tissue samples. Formalinfixation and paraffin-embedding (FFPE) represents the standard method to preserve these clinical tissue samples. However, formalin-fixation introduces severe DNA damage, which restricts current DNA methylation analysis. The present study responds to this substantial limitation by examining the usability of Illumina's DNA restoration protocol to allow for routinely analysis of formalin-fixed tissue specimens with the Infinium HumanMethylation450 technology. It is hypothesized that the HumanMethylation450 microarray in conjugation with Illumina's Infinium HD FFPE DNA Restoration solution can be successfully employed as a discovery assay. To test this hypothesis, differentially methylated CpG sites between FFPE colon tissues and breast cancer specimens have been identified by 450K methylation microarray analysis, followed by validation with nested methylation specific PCR (MSP). This study also statistically assessed the performance of fresh frozen (FF), FFPE DNA-unrestored and FFPE DNA-restored colon tissue samples on the Infinium HumanMethylation450 microarray. The present study showed good correlation between matched FF and FFPE DNA-restored tissue specimens. The presence of a significant bias in methylation assignment introduced by formalin-fixation Introduction DNA methylation is a biochemical process that attaches chemical tags called methyl-groups to cytosine DNA nucleotides. These methyl-groups switch genes off or on by affecting interactions between DNA and the cell's gene-reading machinery (1, 2) . DNA methylation occurs predominantly on cytosines within cytosine-guanine (CpG) dinucleotides, which are frequently concentrated in large clusters called CpG islands (3) . Normal cells are subjected to a well-balanced DNA methylation, which is essential for maintaining cellular function (4). DNA methylation is, however, also involved in a myriad of cancers and other diseases, which has raised wide interest in the development of methods for genome-wide DNA methylation profiling (5)Wingdings fonts also offer arrows in careful gradations of weight and different directions and styles. For variety and impact as bullets, asterisks, and ornaments, Windings also offers a varied set of geometric circles, squares, polygons, targets, and stars.. In 2011, Illumina introduced the Infinium HumanMethylation450 microarray (Infinium Methylation 450K; Illumina, Inc. CA, USA), which makes it possible to assess the methylation status of 485.512 cytosines distributed across the entire human genome. Each Infinium probe reports a β-value, which represents the ratio between methylated probe intensity and overall probe intensity, ranging between 0 (least methylated) and 1 (most methylated). The 450K methylation microarray is regarded as the most attractive, powerful, and cost-effective technique currently available for generating genome-wide DNA methylation profiles in clinical tissue samples (6, 7) . Formalin-fixation and paraffin-embedding (FFPE) represents the standard method to preserve these clinical tissue samples, with over 400 million FFPE tissue samples archived in biobanks worldwide (8 
Material and methods
This study assessed the performance of matched fresh frozen (FF), FFPE DNAunrestored and FFPE DNA-restored non-neoplastic colon tissue samples on the Infinium
HumanMethylation450 microarray. The present study also identified differentially methylated CpG-probes between FFPE non-neoplastic colon tissues and breast cancer specimens by 450K methylation microarray analysis, followed by cross-validation with nested methylation specific PCR (MSP). Nested MSP is a molecular technique that involves methylation-dependent DNA amplification to rapidly determine the methylation status of multiple CpG-loci within a CpG-island.
Results

Correlation between FF and FFPE Sample Methylation
The colon tissue dataset consisted of subgroups, with every subgroup containing a FF, 
Methylation Signal Intensity Analysis
The 450K methylation array is a two-color assay that employs two different assay technologies to quantitatively measure methylation levels. The raw methylated and unmethylated signal intensities are represented as red and green color channels, which correspond to the unmethylated and methylated state respectively. To assess the 450K methylation microarray for a bias in methylation assignment introduced by formalin-
Validation of DNA methylation profiling in formalin-fixed paraffin-embedded colon and breast tissue using the Infinium HumanMethylation450 Microarray H.R. Slaats fixation, the red/green signal intensity ratio was calculated for FF, FFPE DNA-unrestored and FFPE DNA-restored colon samples (figure 2). The red/green-ratio's did not significantly differ between the three fixation methods, with even the poor-quality DNA derived from FFPE DNA-unrestored colon samples not reaching significance.
Figure 2.
Red/green signal intensity analysis. The mean (± SD) ratio between the red (unmethylated) and green (methylated) signal intensities has been visualized for FF, FFPE DNAunrestored and FFPE DNA-restored colon samples.
Cross-Validation of the 450K Results with Methylation Specific PCR
To validate the discovery potential of the 450K methylation microarray, the 450K results were cross-validated with nested MSP. A selection of differentially methylated CpG-probes between formalin-fixed breast cancer specimens and non-cancerous colon tissues was used to validate Illumina's 450K methylation microarray. CpG-probes with an average β-value lower than 0.2 in one dataset and higher than 0.5 in the other were considered differentially methylated. These stringent conditions were applied to ensure sufficient specificity, as nested MSP is highly sensitive for the detection of low methylation levels. 
Input Titration Analysis
The ultimate success of the 450K methylation assay strongly depends on using an accurately quantified amount of input DNA. Illumina recommends to use a minimal amount of 500ng of DNA for the manual 450K methylation assay. To test whether robust results could also be realized with a lower amount of input DNA, the CpG methylation status was compared between technical colon replicates that were analyzed on the 450K methylation microarray using a variable amount of input DNA. The concordance between the technical replicates was calculated in terms of Euclidean distance, with a decreasing Euclidean distance corresponding to a higher similarity between the replicates. 
Correlation of Tissue Sample Variability with FFPE Block Age
Besides the type of fixation and the amount of input DNA, FFPE sample block age can contribute to problems in diagnostic testing. Advanced FFPE sample block age corresponds to elevated levels of DNA fragmentation, which may affects the overall success of the Infinium process. To test this, the percentage of differentially methylated CpG-probes between colon and breast sample replicates has been assessed in relation to the FFPE sample block age. Figure 4 reveals no significant correlation between tissue sample variability and FFPE block age, which suggests that the length of FFPE storage has no influence on sample variability. Another possibility involves a reduction in the amount of amplification cycles used for the PCR reactions, which would also reduce the sensitivity of the MSP assay. An alternative approach applies more stringent conditions used for identifying the differentially methylated CpG-probes. It is, however, important to note that β-value averages rather than individual β-values have been used for identification of the differentially methylated CpG-probes. This implies that the presence of sample outliers need to be taken into account, which explains the low methylation percentages in most of the sample datasets that were expected to turn out unmethylated.
The Infinium platform strongly depends on using an accurately quantified amount of input DNA. In contrast to Illumina's recommendation of using a minimal amount of 500ng of input DNA, current input titration analysis suggests that the cut-off value for a proper 450K array analysis lies much lower, namely between the 75 and 100ng of input DNA. However, current input titration analysis does not allow for a well-substantiated conclusion, as the analysis only includes a limited number of colon replicates. Moreover, Illumina's recommended input DNA quantity is excluded from the analysis. Thus, a more reliable and conclusive input titration analysis requires an increase in sample size as well as expansion of the input quantity range.
Besides sufficient DNA quantity, accurate genome-wide methylation profiling on the 450K platform depends on an adequate DNA quality. Despite the detrimental effect of advanced FFPE block age on DNA integrity, the present study could not detect a significant correlation between tissue sample variability and FFPE block age (15) . This suggests that the genomic DNA quality assessment -which constitutes the first step of the methylation microarray protocol -succeeds in excluding poor-quality DNA from further analysis and, thereby, make the Infinium platform independent of FFPE block age. However, this opposes previous research by Dumenil et al. who showed a significant correlation between sample variability and FFPE block age, which suggests that FFPE block age negatively influences the 450K array analysis despite employment of the genomic DNA quality assessment (11) .
These inconsistent results together with the fact that FFPE blocks used in discovery assays are generally of advanced age encourage to merit further research into the impact of FFPE block age on the Infinium assay. Further research should engage on a broad range of FFPE block ages with an evenly distributed sample set, which have not been provided in both the present study and previous research.
In conclusion, the present study suggests that the Infinium HumanMethylation450 platform can be used successfully on FFPE sample material in conjugation with Illumina's Infinium HD FFPE DNA restoration solution and that the resulting data will be concordant to that of corresponding FF DNA samples. The discovery potential of the methylation
Validation of DNA methylation profiling in formalin-fixed paraffin-embedded colon and breast tissue using the Infinium HumanMethylation450 Microarray H.R. Slaats microarray, however, remains to be elucidated. Since the ultimate success of the 450K platform depends on an accurately quantified amount of input DNA as well as a robust DNA quality, this study also encourages more extensive evaluation of the required input titration and the impact of FFPE block age on the 450K array results.
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